MDXG Q1 2025 Earnings — MiMedx Group, Inc. Revenue & Financial Results | Market Cap Arena

MDXGMiMedx Group, Inc.

$684M

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$88M+4.1% YoY

Gross Profit

$72M81.2% margin

Operating Income

$8M9.4% margin

Net Income

$7M8.0% margin

EPS (Diluted)

$0.05

QoQ Revenue Growth

-5.1%

Cash Flow

Operating Cash Flow

$5M

Free Cash Flow

$5M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$270M

Total Liabilities

$68M

Stockholders' Equity

$203M

Cash & Equivalents

$106M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$88M	$85M	+4.1%
Gross Profit	$72M	$72M	+0.2%
Operating Income	$8M	$13M	-37.5%
Net Income	$7M	$9M	-24.2%

Revenue Segments

Surgical

$32M100%